Prostate Cancer - Results from #2220

JNM Publishes Consensus Statement on Patient Selection and Appropriate Use of Lu-177 PSMA-617 Radionuclide Therapy September 6, 2023

Prostate cancer-multiparametric MRI and alternative approaches in intervention and therapy planning. September 6, 2023

Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trial. September 6, 2023

Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression. September 6, 2023

Emerging role of miRNA in prostate cancer: A future era of diagnostic and therapeutics. September 6, 2023

Androgen deprivation therapy in localized prostate cancer. Current status and future trends. September 6, 2023

SpaceOAR hydrogel distribution and early complications in patients undergoing radiation therapy for prostate cancer. September 5, 2023

Barrigel Spacer Injection Technique. September 5, 2023

Stereotactic Body Radiation Therapy: A Radiosurgery Society Guide to the Treatment of Localized Prostate Cancer Illustrated by Challenging Cases. September 5, 2023

Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer. September 5, 2023

Observer preference of artificial intelligence-generated versus clinical prostate contours for ultrasound-based high dose rate brachytherapy. September 5, 2023

Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working Group. September 5, 2023

The role of PSMA PET/CT to predict upgrading in patients undergoing radical prostatectomy for ISUP grade group 1 prostate cancer. September 5, 2023

Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection. September 4, 2023

A Clinical Role of PET-MRI in Prostate Cancer ? September 4, 2023

Prediction of Response to 177Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC. September 4, 2023

Differentiation of patients with and without prostate cancer using urine 1 H NMR metabolomics. September 4, 2023

Characterization of Google Search Volumes and Trends From 2004 to 2021 for Diagnosis and Treatment of Locally Advanced Prostate Cancer. September 4, 2023

Development and Validation of a New BAG-1L Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer. September 4, 2023

Impact of exercise on continence in prostate cancer patients post robotic assisted radical prostatectomy: a systematic review. September 4, 2023

Page 112 of 1439